26 March 2025
Oxford Nanopore Technologies plc (the "Company")
Director/PDMR Notification
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
The Company has been notified that, on 25 March 2025, Kate Priestman, a Non-Executive Director of the Company and a Person Discharging Managerial Responsibilities, purchased a total of 17,726 ordinary shares in the Company at a price of £1.120324 per share.
This announcement is made pursuant to the Company's obligations under Article 19(3) of the UK Market Abuse Regulation.
Kate Priestman - purchase of shares
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Kate Priestman | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Non-Executive Director | ||||
| b) | Initial/Amendment notification | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Oxford Nanopore Technologies plc | ||||
| b) | LEI | 213800IRWQ2Q6M2CDW55 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of £0.0001 each
GB00BP6S8Z30 | ||||
| b) | Nature of the transaction | Purchase of shares in the Company. | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Aggregated price |
17,726 shares £19,858.86 | ||||
| e) | Date of the transaction | 25 March 2025 | ||||
| f) | Place of the transaction | London Stock Exchange (XLON) | ||||
Enquiries:
Investors
ir@nanoporetech.com
Media
media@nanoporetech.com
OxfordNanoporeTechnologies@teneo.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
